AdaptHealth (AHCO) Hisse Özeti
AdaptHealth Corp. iştirakleri ile birlikte Amerika Birleşik Devletleri'nde evde tıbbi ekipman (HME), tıbbi malzeme ve ev ve ilgili hizmetlerin dağıtımını yapmaktadır. Daha fazla detay
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 6/6 |
| Gelecekteki Büyüme | 3/6 |
| Geçmiş Performans | 0/6 |
| Finansal Sağlık | 3/6 |
| Temettüler | 0/6 |
Ödüller
Risk Analizi
AHCO Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
AdaptHealth Corp. Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | US$5.39 |
| 52 Haftanın En Yüksek Seviyesi | US$13.43 |
| 52 Haftanın En Düşük Seviyesi | US$5.21 |
| Beta | 1.46 |
| 1 Aylık Değişim | -50.46% |
| 3 Aylık Değişim | -48.42% |
| 1 Yıllık Değişim | -43.91% |
| 3 Yıllık Değişim | -53.57% |
| 5 Yıllık Değişim | -77.22% |
| Halka arzdan bu yana değişim | -43.85% |
Son Haberler & Güncellemeler
Anlatı Güncellemesi • Aug 19
AHCO: Capitation Agreements And Cost Efficiencies Will Shape Future Earnings Profile
Analysts have trimmed their average price targets on AdaptHealth to a range of about $8 to $10 from prior levels between $14 and $18, citing softer revenue expectations, a higher required return, and lower assumed future P/E multiples, even as they point to improving margins and business focus after recent portfolio changes. Analyst Commentary Recent Street research on AdaptHealth points to a mix of concern and guarded optimism.Analiz Makalesi • Aug 10
Time To Worry? Analysts Just Downgraded Their AdaptHealth Corp. (NASDAQ:AHCO) Outlook
One thing we could say about the analysts on AdaptHealth Corp. ( NASDAQ:AHCO ) - they aren't optimistic, having just...Analiz Makalesi • Aug 07
AdaptHealth Corp. Just Missed Earnings; Here's What Analysts Are Forecasting Now
One of the biggest stories of last week was how AdaptHealth Corp. ( NASDAQ:AHCO ) shares plunged 43% in the week since...Recent updates
Anlatı Güncellemesi • Aug 19
AHCO: Capitation Agreements And Cost Efficiencies Will Shape Future Earnings Profile
Analysts have trimmed their average price targets on AdaptHealth to a range of about $8 to $10 from prior levels between $14 and $18, citing softer revenue expectations, a higher required return, and lower assumed future P/E multiples, even as they point to improving margins and business focus after recent portfolio changes. Analyst Commentary Recent Street research on AdaptHealth points to a mix of concern and guarded optimism.Analiz Makalesi • Aug 10
Time To Worry? Analysts Just Downgraded Their AdaptHealth Corp. (NASDAQ:AHCO) Outlook
One thing we could say about the analysts on AdaptHealth Corp. ( NASDAQ:AHCO ) - they aren't optimistic, having just...Analiz Makalesi • Aug 07
AdaptHealth Corp. Just Missed Earnings; Here's What Analysts Are Forecasting Now
One of the biggest stories of last week was how AdaptHealth Corp. ( NASDAQ:AHCO ) shares plunged 43% in the week since...Anlatı Güncellemesi • Aug 05
AHCO: Capitation Expansion And Cost Efficiencies Will Drive Future Earnings Profile
Analysts trimmed their fair value estimate for AdaptHealth from $12 to $10, citing higher discount rate assumptions, softer revenue growth expectations, a lower future P/E multiple, and updated views following the divestment of the diabetes business, new capitation agreements, and the recent cyberattack. Analyst Commentary on AdaptHealth Recent Street research on AdaptHealth shows a mix of optimism and caution.Anlatı Güncellemesi • Jul 21
AHCO: Business Mix Shift And Cybersecurity Response Will Shape Future Earnings Profile
Analysts have increased their fair value estimate for AdaptHealth to $12.00 from $11.00. This change reflects updated views on growth, margins and potential multiple support following recent price target changes and shifts in the business mix.
Anlatı Güncellemesi • Jul 06
AHCO: Cyber Resilience And Execution Will Support Future Cash Flow Repricing
The updated analyst price target for AdaptHealth has been revised from $18 to $16, as analysts factor in the recent cyberattack while still reflecting modestly adjusted expectations for revenue growth, profit margins, and future P/E assumptions. Analyst Commentary Recent research on AdaptHealth shows a mix of cautious adjustments and ongoing confidence, as bullish analysts refine their models in light of the cyberattack and other company specific developments.Anlatı Güncellemesi • Jun 22
AHCO: Tuck In Acquisitions And Refinancing Will Shape Future Earnings Profile
AdaptHealth’s latest Narrative Update reflects a modest adjustment to the analyst price target of around $11, as analysts incorporate slightly higher assumed revenue growth, profit margin, and discount rate, along with a marginally lower future P/E multiple in their models. Analyst Commentary on AdaptHealth Recent Street research on AdaptHealth points to a mixed but cautious tone.Anlatı Güncellemesi • Jun 06
AHCO: Capitation Contract Execution Will Support Future Cash Flow Repricing
Narrative Update on AdaptHealth Analysts lifted the fair value estimate for AdaptHealth stock from $17 to $18, reflecting recent price target revisions across several firms that cite updated views on the company’s outlook and valuation assumptions. Analyst Commentary Recent Street research on AdaptHealth has centered on a series of price target resets, with several bullish analysts adjusting their models and one taking a more cautious stance.Anlatı Güncellemesi • May 22
AHCO: Capitated Contract Investments And Legal Settlement Will Shape Future Earnings Profile
Analysts have nudged their average price target on AdaptHealth higher to about $11.00 from $9.50, reflecting updated views on valuation inputs such as a higher assumed future P/E multiple and recent mixed target changes across firms raising and lowering their dollar-based estimates. Analyst Commentary Recent Street research on AdaptHealth reflects a mix of optimism and caution, with some firms lifting price targets and others trimming them as they reassess assumptions around earnings quality, execution and balance sheet risk.Anlatı Güncellemesi • Apr 25
AHCO: Capitated Contract Ramp And Legal Settlement Will Pressure Future Earnings
Analysts have nudged their price targets for AdaptHealth higher by about $1 to $1.50, citing updated views on discount rates, revenue growth, profit margins, and future P/E assumptions reflected in the latest model tweaks. Analyst Commentary Recent research updates show a mixed but generally cautious tone around AdaptHealth, even as some targets move higher at the margin.Anlatı Güncellemesi • Apr 10
AHCO: Capitation Contract Execution Will Drive Future Cash Flow Upside
Narrative Update on AdaptHealth Analysts have trimmed their price targets on AdaptHealth, with recent moves including cuts to $9.50 and $14. This reflects mixed views as they weigh operational progress, new capitation business, and recent EBITDA shortfalls and legal costs.Anlatı Güncellemesi • Mar 27
AHCO: Forward Contract Ramp And Legal Settlement Will Pressure Profitability
Analysts have trimmed AdaptHealth's consensus price target by $1 to $9.50, reflecting updated views on fair value, discount rates, and profitability after recent operational and legal developments. Analyst Commentary Bearish analysts have recently reset expectations on AdaptHealth, trimming price targets and calling out execution risks tied to both operations and legal events.Anlatı Güncellemesi • Mar 13
AHCO: Capitation Ramp And Cash Generation Will Drive Future Upside Potential
Analysts have trimmed their price targets on AdaptHealth, with recent cuts such as $10.50 to $9.50 and $15 to $14. These changes reflect updated views on the impact of increased upfront investment in a major capitated contract and a debt collection settlement on near term earnings.Anlatı Güncellemesi • Feb 27
AHCO: Capitation Ramp And Aging At Home Focus Will Support Upside
Narrative Update on AdaptHealth Analysts have trimmed their price targets on AdaptHealth, with recent cuts such as $10.50 to $9.50 and $15 to $14. These changes reflect updated views on the company after operational progress in 2025 was offset by the timing of investments to ramp a large capitated contract and a debt collection legal settlement in North Carolina that affected adjusted EBITDA versus guidance and estimates.Anlatı Güncellemesi • Feb 13
AHCO: Connected Health Initiative Will Support Aging At Home Upside
Analysts have kept their $17.00 price target for AdaptHealth unchanged, citing slightly adjusted assumptions around the discount rate, revenue growth, profit margins, and future P/E as the main reasons for maintaining their view. What's in the News AdaptHealth is participating in a new Digital Medicine Society initiative focused on using connected health technology to support independent living for older adults at home.Anlatı Güncellemesi • Jan 30
AHCO: Digital Home Health Initiative Will Support Aging At Home Upside
Analysts are holding their fair value estimate for AdaptHealth at US$17.00 per share, citing only modest tweaks to assumptions around discount rate, revenue growth, profit margin and future P/E that do not materially change their overall view. What's in the News AdaptHealth is participating in a Digital Medicine Society initiative focused on technology driven support for older adults living independently, working alongside partners including Validic, Epic Systems, Verizon and Withings to expand connected care and remote monitoring capabilities (Key Developments).Anlatı Güncellemesi • Jan 16
AHCO: Digital Home Health Initiative Will Support Aging At Home Opportunity
Analysts have lifted their price target on AdaptHealth from US$16.00 to US$17.00 as they factor in updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. What's in the News AdaptHealth is participating in a Digital Medicine Society initiative focused on technology driven support for independent living among older adults, working alongside partners such as Validic, Epic Systems, Verizon, and Withings within the Connected Health Collaborative.Analiz Makalesi • Jan 03
AdaptHealth (NASDAQ:AHCO) Takes On Some Risk With Its Use Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analiz Makalesi • Oct 18
Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Analiz Makalesi • Aug 08
AdaptHealth Corp. Just Missed EPS By 31%: Here's What Analysts Think Will Happen Next
NasdaqCM:AHCO 1 Year Share Price vs Fair Value Explore AdaptHealth's Fair Values from the Community and select yours...Analiz Makalesi • Jul 23
Insufficient Growth At AdaptHealth Corp. (NASDAQ:AHCO) Hampers Share Price
AdaptHealth Corp.'s ( NASDAQ:AHCO ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a buy right now...Analiz Makalesi • Jun 26
Is It Time To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?
AdaptHealth Corp. ( NASDAQ:AHCO ), might not be a large cap stock, but it led the NASDAQCM gainers with a relatively...Seeking Alpha • Jun 02
AdaptHealth At A Crossroads: Automation, Integration, And The Future Of Home Care
Summary AdaptHealth's national scale and AI-driven efficiencies position it well for value-based contracts, aiming to curb hospital readmissions and improve EBITDA margins. The company faces potential risks from competitive-bidding discounts, unresolved litigation, and execution challenges on the One Adapt ERP migration. Management's 2025 guidance suggests flat organic revenue and a 21% EBITDA margin, with shares appearing undervalued compared to peers. Long-term investors may find value in accumulating shares below 7× forward EBITDA, while monitoring integration milestones and CMS policy developments. Read the full article on Seeking Alpha
Yeni Anlatı • May 15
Adapt Operating System And Debt Reduction Will Transform Home Healthcare
AdaptHealth's focus on geographic expansion, managed care, and partnerships aims to boost market share and drive revenue growth in the home health industry.Analiz Makalesi • May 14
We Think AdaptHealth's (NASDAQ:AHCO) Solid Earnings Are Understated
AdaptHealth Corp.'s ( NASDAQ:AHCO ) recent earnings report didn't offer any surprises, with the shares unchanged over...Analiz Makalesi • May 09
AdaptHealth Corp. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
AdaptHealth Corp. ( NASDAQ:AHCO ) last week reported its latest quarterly results, which makes it a good time for...Analiz Makalesi • Apr 07
Little Excitement Around AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues
AdaptHealth Corp.'s ( NASDAQ:AHCO ) price-to-sales (or "P/S") ratio of 0.4x may look like a pretty appealing investment...Analiz Makalesi • Mar 20
At US$10.02, Is It Time To Put AdaptHealth Corp. (NASDAQ:AHCO) On Your Watch List?
AdaptHealth Corp. ( NASDAQ:AHCO ), might not be a large cap stock, but it saw a decent share price growth of 19% on the...Analiz Makalesi • Feb 26
These 4 Measures Indicate That AdaptHealth (NASDAQ:AHCO) Is Using Debt Extensively
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analiz Makalesi • Jan 30
Be Wary Of AdaptHealth (NASDAQ:AHCO) And Its Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analiz Makalesi • Dec 10
AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues Are Not Doing Enough For Some Investors
When close to half the companies operating in the Healthcare industry in the United States have price-to-sales ratios...Analiz Makalesi • Nov 13
We Think AdaptHealth (NASDAQ:AHCO) Is Taking Some Risk With Its Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analiz Makalesi • Oct 22
Returns On Capital Signal Tricky Times Ahead For AdaptHealth (NASDAQ:AHCO)
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Analiz Makalesi • Sep 06
AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
AdaptHealth Corp. ( NASDAQ:AHCO ) shareholders would be excited to see that the share price has had a great month...Analiz Makalesi • Jul 14
Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, AdaptHealth fair value estimate is US$16.89 Current share...Analiz Makalesi • Jun 25
AdaptHealth Corp.'s (NASDAQ:AHCO) Low P/S No Reason For Excitement
When close to half the companies operating in the Healthcare industry in the United States have price-to-sales ratios...Analiz Makalesi • Jun 04
AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Hissedar Getirileri
| AHCO | US Healthcare | US Pazar | |
|---|---|---|---|
| 7D | -7.2% | -1.5% | -2.1% |
| 1Y | -43.9% | 23.0% | 18.8% |
Getiri vs. Endüstri: AHCO geçen yıl % 23 oranında getiri sağlayan US Healthcare sektörünün gerisinde kaldı.
Getiri vs Piyasa: AHCO geçen yıl % 18.8 oranında getiri sağlayan US Piyasasının altında performans gösterdi.
Fiyat Oynaklığı
| AHCO volatility | |
|---|---|
| AHCO Average Weekly Movement | 12.4% |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
İstikrarlı Hisse Senedi Fiyatı: AHCO hisse senedi fiyatı, son 3 ayda US piyasasına kıyasla dalgalı seyretti.
Zaman İçindeki Volatilite: AHCO 'nin haftalık oynaklığı ( 12% ) geçen yıl boyunca sabit kaldı, ancak hala US hisselerinin %75'inden yüksek.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 2012 | 10,900 | Suzanne Foster | adapthealth.com |
AdaptHealth Corp. iştirakleri ile birlikte Amerika Birleşik Devletleri'nde evde tıbbi ekipman (HME), tıbbi malzeme ve ev ve ilgili hizmetlerin dağıtımını yapmaktadır. Uyku Sağlığı, Solunum Sağlığı, Diyabet Sağlığı ve Evde Sağlık segmentleri aracılığıyla faaliyet göstermektedir. Şirket, obstrüktif uyku apnesinden muzdarip bireylere sürekli pozitif hava yolu basıncı ve BiLevel hizmetleri gibi uyku terapisi ekipmanı, malzemeleri ve ilgili hizmetler; oksijen ve evde mekanik ventilasyon ekipmanı ve malzemeleri ve ilgili kronik terapi hizmetleri; ve diyabet tedavisi için sürekli glikoz monitörleri ve insülin pompaları dahil olmak üzere tıbbi cihazlar; akut bakım ve diğer tesislerden taburcu edilen hastalara HME ve diğer HME cihazları ve malzemeleri sunmaktadır.
AdaptHealth Corp. Temel Bilgiler Özeti
| AHCO temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | US$719.08m |
| Kazançlar(TTM) | -US$231.09m |
| Gelir(TTM) | US$3.36b |
0.2x
P/S Oranı-3.1x
F/K OranıAHCO aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| AHCO gelir tablosu (TTM) | |
|---|---|
| Gelir | US$3.36b |
| Gelir Maliyeti | US$2.72b |
| Brüt Kâr | US$644.93m |
| Diğer Giderler | US$876.03m |
| Kazançlar | -US$231.09m |
Son Raporlanan Kazançlar
Jun 30, 2026
Sonraki Kazanç Tarihi
n/a
| Hisse başına kazanç (EPS) | -1.73 |
| Brüt Marj | 19.18% |
| Net Kâr Marjı | -6.87% |
| Borç/Özkaynak Oranı | 136.2% |
AHCO uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görünŞirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/08/21 19:08 |
| Gün Sonu Hisse Fiyatı | 2026/08/20 00:00 |
| Kazançlar | 2026/06/30 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
AdaptHealth Corp. 11 Bu analistlerden 7, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Eric Coldwell | Baird |
| Kevin Fischbeck | BofA Global Research |
| Joanna Sylvia Gajuk | BofA Global Research |